SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001213900-24-010231
Filing Date
2024-02-06
Accepted
2024-02-06 06:14:44
Documents
3

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea192779-8k425_phoenix.htm 425 68899
2 AMENDMENT NO. 1 TO BUSINESS COMBINATION AGREEMENT, DATED AS OF FEBRUARY 5, 2024, ea192779ex2-1_phoenix.htm EX-2.1 20509
3 SECURITIES PURCHASE AGREEMENT, DATED AS OF FEBRUARY 5, 2024, BY AND AMONG CERO T ea192779ex10-1_phoenix.htm EX-10.1 1632606
  Complete submission text file 0001213900-24-010231.txt   1723758
Mailing Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103 2157319450
PHOENIX BIOTECH ACQUISITION CORP. (Filed by) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103 2157319450
PHOENIX BIOTECH ACQUISITION CORP. (Subject) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-40877 | Film No.: 24598012
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)